Announced Fri, 10 Jul · 17:49 IST
Subsidiary Natural Biogenex approves rights issue of 1.12 crore at par
Corporate Actions View source PDF
NATCAPSUQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.1%1-day move
₹143.50
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-0.1-1.0-0.4-1.1-2.8-1.7————
Up moveDown movePending
AI summary
Natural Capsules Limited informed the exchange that its material unlisted subsidiary, Natural Biogenex Private Limited, has approved a Rights Issue of 11,16,766 equity shares of Rs. 10 each at par, totalling about Rs. 1.12 crore. The decision was taken at the subsidiary's board meeting held on July 10, 2026.
Likely market impact
Small capital raise at the subsidiary level at par value; limited direct impact on the listed company's shareholders.